glp 1 drugs blindness GLP-1s and Eye Health: What You Need to Know Possible Link Between GLP-1 RA
Description
Why will it take 18 more months to start BALANCE

Kim S, Moon M, Park S

This multi-layered approach allows providers to make evidence-based, individualized decisions about which GLP-1/GIP agent best fits your unique health context, moving beyond one-size-fits-all prescribing toward precision wellness

In diabetes care, GLP-1 drugs remain part of a structured, guideline-driven approach focused on glycemic control and long-term complication prevention

Real-world effectiveness often differs from controlled trial results